PARK7 and ovarian cancer: Lovastatin, which possesses cholesterol-lowering and potential antineoplastic activities, induces apoptosis in ovarian cancer cells by inducing PTEN and reducing phosphor-AKT via inhibition of PARK7 expression [90].